The WaveWatch Group exists to serve three distinct markets: Cardiology Practices, Pharma and Contract Research Organizations (CRO), and Hospital and Physician groups. These populations are impacted by ECG overreads in real‐time: critical patient care issues, 24/7 operating environments, huge exposure to adverse conditions of dosing and efficacy. We have three distinct operating departments to address these organizations, with key personnel and expertise in each area: